Nomination Committee for AGM 2022

In preparation for the annual general meeting 2022, the company’s three largest shareholders, or groups of shareholders, have appointed members of the nomination committee. The nomination committee consists of the following members:

• Daniel Johnsson, chairman of the nomination committee, entrepreneur, business developer and investor, appointed by a group of shareholders representing about 21 percent of shares and votes;
• Bo Rydlinger, background from banking and investments, appointed by a group of shareholders representing about 15 percent of shares and votes;
• Clas Sonesson, Chief Scientific Officer (CSO) at IRLAB and one of IRLAB’s founders. Appointed by a group of shareholders that consists of the company’s founders representing about 10 percent of shares and votes; and
• Gunnar Olsson, chairman of the board of IRLAB Therapeutics AB.

The nomination committee’s proposal has been presented in the summon to the annual general meeting 2022 and on the company’s web page – irlab.se.

The nomination committee’s proposal and motivated opinion 2022 (in Swedish) can be found via this link.